Skip to main content

Day: May 25, 2023

BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp.

Special Shareholder Meeting to be Held in July 2023PHILADELPHIA and VANCOUVER, British Columbia, May 25, 2023 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, is pleased to announce that it has entered into an arrangement agreement dated May 24, 2023 with BriaPro Therapeutics Corp. (“SpinCo”), a wholly-owned subsidiary of the Company (the “Arrangement Agreement”) pursuant to which certain pre-clinical pipeline assets of the Company, including Bria-TILsRx™ and protein kinase C delta (PKCδ) inhibitors for multiple indications including cancer (the “SpinCo Assets”), will be spun-out to SpinCo by way of a court approved statutory plan of arrangement under the Business Corporations...

Continue reading

Harbor Custom Development, Inc. Announces Updates on Multi-Family Projects in Washington

TACOMA, Wash, May 25, 2023 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (Nasdaq: HCDI, HCDIP, HCDIW, HCDIZ) (“Harbor,” “Harbor Custom Homes®,” or the “Company”), a real estate company involved in all aspects of the land development cycle, today announced an update on the Company’s six multi-family projects. Harbor made a strategic pivot in the Company’s Western Washington portfolio last year, from single-family homes to focus on the development and construction of multi-family communities. The Company listed six multi-family projects with Kidder Matthews in April 2022. The first two projects are anticipated to close in June 2023 – Mills Crossing townhomes, a completed 36-unit townhome project in Bremerton, Washington, and Bridge View Trail apartments, a fully entitled and developed...

Continue reading

Siguldas CMAS JSC Unaudited financial information for the first three months of the year 2023

In the first three months of 2023 net turnover was 397.9 thousand euros, showing an increase of 9.1% against the corresponding period in 2022, whereas profit before taxes was 66.9 thousand euros – by 20.7 thousand euros less compared to the corresponding period in 2022. JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ is one of the largest high-quality breeding bull semen producers and suppliers in Latvia. The second largest field of the Company’s basic economic activities is milk testing services. The Company also provides other breeding related services – consultations on issues of cattle breeding, feeding and keeping, evaluation of cow exterior, artificial insemination of cows, initial processing of the monitoring data. Valda Mālniece Member of the Management Board, Manager of the Financial and Accounting department E-mail:...

Continue reading

Alchip Technologies Sets Record Q1 Revenue

North America Accounts for 63 Percent of Revenue2023 Q1 Revenue Breakdown by Region Alchip Technologies reported that 63 percent of its record $188 million first quarter 2023 revenue came from the fast-growing North America region.Taipei, Taiwan, May 25, 2023 (GLOBE NEWSWIRE) — Alchip Technologies has reported record revenue of USD$188 million for the first quarter of its 2023 fiscal year, topping first quarter FY2022 revenue of USD$93.5 million by 101.2 percent, and fourth quarter FY2022 revenue of USD$148.3 million by 26.8 percent.  The Company also reported record earnings per share of NT$8.09. First quarter FY2023 operating income reached USD$20.9 million, a 7 percent increase over first quarter FY2022 operating income of USD$19.6 million, and a 4.5 percent increase over fourth quarter FY2022 operating income of USD$20...

Continue reading

Heparin Market Size to Surpass USD 13.22 Billion by 2030, exhibiting a CAGR of 4.2%

As per the report by Fortune Business Insights, the global Heparin Market size is projected to reach USD 13.22 Billion by 2030, at a CAGR of 4.2% during the forecast period. Pune, India, May 25, 2023 (GLOBE NEWSWIRE) — The global heparin market size was valued at USD 9.53 billion in 2022. The market is projected to grow from USD 9.89 billion in 2023 to USD 13.22 billion by 2030, displaying a CAGR of 4.2% during the 2023-2030 forecast period. Increasing cases of chronic disorders globally and rising government initiatives to expand these products’ applications are likely to boost market growth. Fortune Business Insights™ stated this in a report titled, “Global Heparin Market, 2023-2030. Industry DevelopmentWith an aim to increase its distribution channel, Hepalink Group announced the approval of heparin sodium...

Continue reading

JSC “Latvijas Gāze”: Unaudited financial results of JSC “Latvijas Gāze” Group for 3 months of 2023

Latvijas Gāze Group continued to face various challenges in the first quarter of 2023, mainly in connection with significant natural gas price fluctuations. Thanks to the experience accumulated over the years and extensive knowledge of the natural gas market in Latvia and Europe, Latvijas Gāze continued its operations, ensuring an uninterrupted supply of gas to its customers, including fulfilling its obligations as Public Trader towards more than 340 000 household clients. Latvijas Gāze Group’s net profit in the first quarter of 2023 reached 12 million EUR, which was 85% lower compared to the corresponding period of 2022, when the net profit was 77.5 million EUR.  The significant decrease in profit can be explained by the fact that the result of the economic activity of the first quarter of 2022, due to the accounting methodology of financial...

Continue reading

A-Mark Precious Metals Closes Previously Announced Purchase of Minority Interest in United Kingdom-Based Atkinsons Bullion & Coins

EL SEGUNDO, May 25, 2023 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that it has closed its previously reported agreement to purchase a 25% ownership interest in the parent company of Atkinsons Bullion & Coins (“Atkinsons”). Founded in 1990, Atkinsons, which reported revenue of over $130 million in calendar 2022, is a leading United Kingdom-based online retailer of precious metals, bullion and coins. In connection with the agreement, A-Mark received an option, exercisable starting in May 2025, to acquire an additional 24.5% ownership interest in Atkinsons, which, if exercised, would increase A-Mark’s ownership interest to 49.5%. A-Mark and Atkinsons have also entered into a three-year supplier agreement which includes a renewal...

Continue reading

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

LAKEWOOD, Colo., May 25, 2023 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q23”) and fiscal year (“FY23”) ended March 31, 2023. Fourth quarter highlights:Fourth quarter revenues decreased 5.6% Fourth quarter Non-GAAP core organic revenues3decreased 1.6% Fourth quarter operating income increased 570% Fourth quarter Non-GAAP adjusted operating income1excluding unusual items decreased 21.1%Full FY23 highlights:FY23 revenues increased 18.8% FY23 Non-GAAP core organic revenues growth was 5.2% FY23 operating income decreased 29.4% FY23 Non-GAAP adjusted operating income excluding unusual items decreased 1.7%Executive Commentary (amounts in thousands) “Revenues...

Continue reading

Sono-Tek Announces Financial Results for Fiscal Year 2023; Positive Net Sales Growth Expected for Fiscal Year 2024

-Backlog at February 28, 2023 Increased 60% to $8.5M Year Over Year; First Year with Several $1+Million Orders – -Conference Call on Thursday, May 25, 2023 at 10:00am EST- MILTON, N.Y, May 25, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2023, ended February 28, 2023 (“fiscal 2023”). Fiscal Year 2023 HighlightsBacklog at February 28, 2023, was $8.5 million, a record high and a 60% increase compared to backlog at February 28, 2022, (“fiscal 2022″). The large increase in backlog resulted from the receipt of several large orders from the clean energy sector during the year. These orders have high average selling prices and longer than typical...

Continue reading

CVRx to Present at the William Blair 43rd Annual Growth Stock Conference

MINNEAPOLIS, May 25, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the William Blair 43rd Annual Growth Stock Conference on Thursday, June 8, 2023. The Company is scheduled to present at the conference at 9:20 am Central Time (10:20 am Eastern Time). A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.cvrx.com. About CVRx, Inc. CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.